Back
Innate Pharma SA Vs. Cellectis SA Industry Stock Comparison
Sell
7
IPHA
Innate Pharma SA
Last Price:
1.45
Seasonality Move:
6.04%
Buy
64
CLLS
Cellectis SA
Last Price:
1.96
Seasonality Move:
2.08%
Sell
7
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $1.45. The Score for IPHA is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
64
Cellectis SA (CLLS)
is a Buy
Is Cellectis SA a Buy, Sell or Hold?
- The current Cellectis SA [CLLS] share price is $1.96. The Score for CLLS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CLLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing selling pressure, which indicates risk of future bearish movement.
CLLS Stock Price Chart
What is Cellectis SA's stock price today?
-
The Cellectis SA share price today is $1.96
The current trend is relatively stagnant and CLLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 36.87 | Sell |
Chaikin Money Flow: | -69244 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.6 - 1.92) | Sell |
Bollinger Bands (100): | (1.86 - 2.3) | Sell |
CLLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 54.41 | Buy |
Chaikin Money Flow: | 80315 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.8 - 1.94) | Buy |
Bollinger Bands (100): | (1.89 - 2.25) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.57 | Sell |
20-day SMA: | 1.74 | Sell |
50-day SMA: | 1.95 | Sell |
200-day SMA: | 2.3 | Sell |
8-day EMA: | 1.61 | Sell |
20-day EMA: | 1.72 | Sell |
50-day EMA: | 1.89 | Sell |
200-day EMA: | 2.23 | Sell |
CLLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.91 | Buy |
20-day SMA: | 1.86 | Buy |
50-day SMA: | 1.97 | Sell |
200-day SMA: | 2.34 | Sell |
8-day EMA: | 1.91 | Buy |
20-day EMA: | 1.9 | Buy |
50-day EMA: | 1.96 | Sell |
200-day EMA: | 2.23 | Sell |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Cellectis SA Earnings Growth & CLLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and a decrease next year of $0.06 per share.
Innate Pharma SA Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cellectis SA Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |